1.Hu Y, Chai D, Geng Q, Chen L, Zhang F, Qiu P, Wang C*, Lu L*, Kong D*. Polyene phosphatidyl choline injection regulates lipid homeostasis via AKT-PDE3-PKA in mice. Biochem Biophys Res Commun. 2025, 5;790:15292(通讯作者,四区) IF:2.5
2.Hu Y, Geng Q, Wang L, Wang Y, Huang C, Fan Z*, Kong D*. Research progress and application of liver organoids for disease modeling and regenerative therapy. J Mol Med (Berl). 2024 Jul;102(7):859-874.(通讯作者,二区)IF:4.2
3.Ping Qiu#, Ai Mi#, Chunlan Hong#, Shuo Huang, Qing Ma, Qihan Luo, Jiang Qiu, He Jiang, Yufan Chen, Fangming Chen, Honghao Yan, Jinkai Zhao, Yu Kong, Yu Du, Changyu Li, Desong Kong*, Thomas Efferth*, Dayong Lou*, An integrated network pharmacology approach reveals that Ampelopsis grossedentata improves alcoholic liver disease via TLR4/NF-κB/MLKL pathway, Phytomedicine, 2024, 132: 155658.(共同通讯作者,一区)IF:8.4
4.Yi Wang; Tong Zhao; Chuyue Huang; Fei Liu; Yang Zhang; Desong Kong*; Zhimin Fan*; Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach, Phytomedicine, 2024, 123: 155174. (共同通讯作者,一区)IF:8.3
5.Geng Q, Xu Y, Hu Y, Wang L, Wang Y, Fan Z, Kong D*. Progress in the Application of Organoids-On-A-Chip in Diseases. Organogenesis. 2024, 31;20(1):1-14. (通讯作者,四区)IF:2.8
6.Geng Q#, Xu Y#, Huang W, Hu Y, Jin H, Hua H, Kong D*. The Potential Mechanism of the Anti-Liver Fibrotic Effect of Curcumin in the Gut-Liver Axis. J Med Food. 2024 May;27(5):404-418. (通讯作者,四区)IF:2.0
7.Siwei Xia, Li Chen, Zhanghao Li, Yang Li, Yuanyuan Zhou, Sumin Sun, Ying Su, Xuefen Xu Jiang juan Shao, Zili Zhang, Desong Kong*, Feng Zhang*, Shizhong Zheng*. Qingchang Wenzhong Decoction reduce ulcerative colitis in mice by inhibiting Th17 lymphocyte differentiation. Phytomedicine, 2022, 107: 154460.(共同通讯作者,一区)IF:7.9
8.Li Chen#; Desong Kong#; Siwei Xia; Feixia Wang; Zhanghao Li; Feng Zhang*; Shizhong Zheng*; Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis. Frontiers in Pharmacology, 2022, 13. (共同第一作者,二区)IF:5.6
9.WF Huang;DS Kong*; The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD. BIOMED PHARMACOTHER, 2021, 135: 111235.(通讯作者,二区)IF:6.529
10.Li-Ping CHEN, Xiao-Qian WU, Zi-Li ZHANG, Ling WANG, Feng ZHANG, Shi-Zhong ZHENG, De-Song KONG*. Evaluate the effect of licorice on anti-liver fibrosis: a systematic review and meta-analysis. Food Sci. Technol, e103321, 2022. (通讯作者,四区)IF:2.602